Great Ormond Street Hospital (GOSH) has signed a deal to transform its research capabilities using data analysis technology.
It will harness Aridhia’s cloud-based data analysis platform, AnalytiXagility, in a 10-year agreement that will reshape the research landscape at GOSH. The secure platform will give scientists quick access to data and analytical tools designed to accelerate the path from research to clinical practice.
Chris Roche, CEO of Aridhia, said: “Great Ormond Street Hospital is world-renowned and it is an honour to be given the opportunity to support such extraordinary researchers deliver ground-breaking research across multiple clinical domains. For Great Ormond Street to select AnalytiXagility after a rigorous 12-month procurement process is great endorsement of our vision to accelerate clinical research.”
“The Trust was seeking a secure, scalable research platform that would allow their teams to collaborate on analysis and deliver rapid, auditable and reproducible results. AnalytiXagility satisfies these requirements. We are very much looking forward to working with them on this next stage of their research journey.”
And the partnership was welcomed by Dr Peter Steer, Chief Executive at the Great Ormond Street Hospital for Children Foundation Trust.
“We look forward to working with Aridhia to develop an innovative platform which will transform the way we undertake and collaborate on research. This will allow us to bring more life-saving treatments to children with rare diseases in the UK and worldwide,” he said.